|
Summary of Unaudited Quarterly financial data (in thousands, except per share data) (Details) (USD $)
|
3 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2013
|
Sep. 30, 2013
|
Jun. 30, 2013
|
Mar. 31, 2013
|
Dec. 31, 2012
|
Sep. 30, 2012
|
Jun. 30, 2012
|
Mar. 31, 2012
|
|
| Summary of Unaudited Quarterly financial data | ||||||||
| Product revenue | $ 5,658 | $ 2,535 | $ 5,581 | $ 4,672 | $ 4,558 | $ 3,418 | $ 6,244 | $ 6,572 |
| Research and development contract revenue | 267 | 462 | 368 | 400 | 226 | 502 | 458 | 515 |
| Net loss attributable to common shareholders | $ (28,929) | $ (15,948) | $ (9,338) | $ (8,576) | $ (8,474) | $ (10,325) | $ (6,480) | $ (6,583) |
| Basic and Diluted | $ (0.28) | $ (0.19) | $ (0.14) | $ (0.18) | $ (0.22) | $ (0.27) | $ (0.17) | $ (0.28) |